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Objective: We compared the effectiveness and clinical outcome of open repair versus endovascular aortic aneurysm repair
(EVAR) in achieving prevention of abdominal aortic aneurysm (AAA)–related death and graft-related complications.
Methods: Over 7 years from 1997 to 2003, 1119 consecutive patients underwent elective treatment of infrarenal AAAs,
585 with open repair and 534 with EVAR. Patients were regularly followed up at 1, 6, 12 months, and every 6 months
thereafter, in EVAR group, and at 3 and 12 months, and yearly thereafter after open repair. Preoperative, intraoperative,
and follow-up data were stored in a prospective database.
Results: Median follow-up was similar in the 2 groups: 33 months (interquartile range [IQR], 13-50 months) in the
EVAR group vs 35 months (IQR, 15-54 months) in the open repair group. EVAR group patients were older than
patients in the open repair group: 73 years vs 72 years (P .04). There were statistical significant differences between the
EVAR group and the open repair group with respect to AAA median diameter (52 mm vs 56 mm), coronary disease rate
(46% vs 37%; P  .001), pulmonary disease rate (56% vs 38%; P < .0001), and American Society of Anesthesiologists IV
score rate (16% vs 6%; P< .0001). Thirty-day mortality in the EVAR group was 0.9% (5 of 534 patients), compared with
4.1% (24 of 585 patients; P .001) in the open repair group, and major morbidity was 9.1% (49 of 534 patients) vs 18.6%
(109 of 585 patients; P < .0001), respectively. The incidence of secondary procedures in the EVAR group was 15.7%,
compared with 3% in the open repair group (P < .0001). There were no deaths related to secondary procedures in either
group. Six AAAs (1.1%) ruptured after EVAR, 3 of which were fatal; in the open repair group 1 patient (0.2%) underwent
successful repeat operatation to treat iliac pseudoaneurysm rupture 5 years after the original procedure. Kaplan-Meier
estimates for freedom from aneurysm-related death at 84 months were 97.5% in the EVAR group and 95.9% in the open
repair group (log rank test, P .008). Kaplan-Meier survival estimates at 84 months were 67.1% in the open repair group
and 66.9% in the EVAR group (PNS). At the same interval the risk for secondary procedures was 49.4% for the EVAR
group and 7.1% for the open repair group. Of the 11 variables analyzed with logistic analysis, open surgery (hazard ratio
[HR], 11; 95% confidence interval [CI], 2.5-54.2; P  .002), American Society of Anesthesiologists IV score (HR, 7.1;
95% CI, 2.7-18.8; P  .0001), and age (HR, 1.06; 95% CI, 1.04-1.13; P  .04) were positive independent predictors of
perioperative mortality.
Conclusion: Our data suggest that at a maximum follow-up of 7 years, patients who undergo EVAR show lower
perioperative and late aneurysm-related mortality compared with a younger and substantially healthier group of patients
with aneurysms treated with open repair. The higher need for secondary procedures in the endovascular group did not
affect superiority of the overall performance of EVAR in the early and late intervals. ( J Vasc Surg 2004;40:841-8.)Since the introduction of endovascular repair (EVAR)
of abdominal aortic aneurysms (AAAs) many studies have
evaluated outcomes of different endovascular grafts. Al-
though several clinical studies, including the 4 US Food
and Drug Administration–approved phase II trials, have
demonstrated reduction in early morbidity compared with
control patients undergoing surgical open repair, a number
of late complications after EVAR have been reported,
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doi:10.1016/j.jvs.2004.08.040which raises questions regarding overall suitability of the
procedure.1-10 At present there is no consensus for recom-
mending EVAR or open repair as the preferred treatment in
most patients.
To compare the outcome and effectiveness of EVAR
versus open repair, we analyzed a consecutive series of 1119
patients with AAAs treated in our unit in a 7-year interval.
Since this was not a randomized study, and patients were
selected according to morphologic suitability and medical
comorbidities, as a secondary objective we evaluated the
influence of patient characteristics on the outcome of both
treatments.
PATIENTS AND METHODS
Between January 1997 and December 2003, 1119
consecutive patients with AAAs had undergone primary
elective repair in a tertiary care university hospital with a
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operative aortic surgery, and patients requiring thoracoab-
dominal or suprarenal aortic reconstruction or repair after
AAA rupture were excluded. Patients with infrarenal AAAs
requiring suprarenal clamping were not excluded.
Patients were selected as possible candidates for EVAR
on the basis of contrast material–enhanced computed to-
mography (CT) with 3-mm to 5-mm cuts. Three-
dimensional vascular reconstructions were performed when
possible. Contrast-enhanced angiography and magnetic
resonance angiography were performed in selected cases.
AAA diameter was measured as the smallest diagonal from
adventitia to adventitia on axial sections.
All data for the 1119 consecutive patients were re-
corded prospectively. Risk factors and morphologic fea-
tures were classified according to the Society for Vascular
Surgery/International Society for Cardiovascular Surgery
reporting standards, and are shown in Table I.11
Open repair was offered in patients with unsuitable
anatomy, including proximal infrarenal aortic neck less than
15 mm long or greater than 30 mm in diameter, proximal
neck angulation greater than 60 degrees, extensive neck
thrombus, access vessel calcifications (more than 50% cir-
cumference involvement) with tortuosity (angulation
60%), common iliac or hypogastric arteries aneurysms
greater than 30 mm in diameter , and associated iliac
occlusive disease (complete obstruction or preocclusive
stenosis 3 cm long).
Anatomic criteria for exclusion from EVAR were less
stringent in patients at high-risk. Open repair was also
offered as a first option in patients with long life expectancy,
based on age and absence of significant comorbid condi-
tions. Indications for open repair are listed in Table II.
Repair procedures. The elective operations were
EVAR in 534 patients (47.7%) and open repair in 585
Table I. Demographic data and risk factors in 1119
patients
Endovascular
repair
(N 534 )
Open
repair
(N  585)
Pn % n %
Age (y) 73 72 .04
IQR 68-77 66-77
Male gender 502 94 527 90 .02
Hypertension 355 66 385 66 NS
Coronary artery disease 248 46 216 37 .001
Renal disease 61 11 57 10 ns
Pulmonary disease 298 56 224 38 .0001
Hyperlipedemia 187 35 177 30 NS
Diabetes mellitus 49 9 40 7 NS
Cerebrovascular disease 76 14 60 10 NS
ASA IV 87 16 36 6 .0001
AAA diameter (mm) 52 56 .001
IQR 47-57 50-65
ASA, American Society of Anesthesiologists; AAA, abdominal aortic aneu-
rysm; IQR, interquartile range; NS, not significant.patients (52.3%). Open repair was performed with thepatient under general anesthesia and approached by either
the transperitoneal (n 521, 89%) or retroperitoneal (n
64, 11%) route, based on patient habitus, presence of severe
respiratory disease, surgical anatomy, or surgeon prefer-
ence. Of the 585 patients undergoing open repair, 311
(53%) received bifurcated aortoiliac grafts, 246 (42%) re-
ceived tubular aortoaortic grafts, and the remaining 28
(5%) received bifurcated aortofemoral grafts. Associated
surgical nonvascular procedures included abdominal wall
hernia repair (n  4), cholecystectomy (n  7), nephrec-
tomy (n 5), colectomy (n 1), and oophorectomy (n
2). In 89 patients (15%) suprarenal clamping was required;
12 of these patients underwent simultaneous renal artery
reconstruction.
A team of vascular surgeons and interventional radiol-
ogists performed all EVARs in an operating room equipped
with a portable C-arm with angiographic and road-
mapping capabilities. In the EVAR group, general anesthe-
sia was used in 240 patients (45%), epidural anesthesia in
242 patients (45%), and local anesthesia in 52 patients
(10%). Four patients in the EVAR group underwent
planned simultaneous renal artery stenting. Endograft con-
figurations included 520 bifurcated grafts (97.3%), 4 tube
grafts (0.7%), and 10 (1.9%) aortouniliac grafts. Endografts
used were AneuRx (Medtronic AVE; n  239, 44.7%,
Zenith (Cook; n  109, 20.4%), Excluder (W. L. Gore &
Assoc; n  71, 13.3%), Talent (Medtronic AVE; n  69,
12.9%), Quantum/Fortron (Cordis, Johnson & Johnson;
n  31, 5.8%), Anaconda (Sulzer Vascutek; n  11, 2.1%,
Endologix (Bard; n  3, 0.5%), and Endofit (Endomed; n
 1, 0.2%).
Patient follow-up. Postoperative surveillance after
open repair consisted of clinical, duplex ultrasound scan-
ning at 3, 6, 12 months, and yearly thereafter. CT or
angiography were performed only when graft-related com-
plications were suspected.
Patients who underwent EVAR were scheduled for
routine clinical follow-up with abdominal x-ray films and
duplex ultrasound scans at 1, 6, 12 months, and every 6
months thereafter. CT was scheduled at 1, 12 months, then
yearly. CT at shorter intervals or angiography were per-
formed when indicated.
Of the entire study cohort, only 1 patient was lost to
Table II. Main indication for open repair (N  585)
n %
Inadequate proximal neck 266 46
Associated iliac aneurysm 85 15
Iliac occlusive disease 27 5
Iliac calcifications 53 9
Horseshoe kidney 6 1
Associated abdominal disease 19 3
Need for renal artery reconstruction 12 2
Inflammatory abdominal aortic aneurysm 10 2
Patient preference 25 4
Long life expectancy 82 14follow-up, 32 months after the original EVAR; 126
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scheduled interval were all recalled and interviewed on the
telephone.
Definitions and statistical analysis. Outcome mea-
sures included perioperative mortality, defined as death
within 30 days after operation or any death occurring
during the same hospitalization; aneurysm rupture; and
aneurysm-related mortality, defined as any death occurring
within 30 days after the primary or secondary aneurysm-
related treatment or any aneurysm-related death at any time
after treatment.12,13
Secondary outcome measures included perioperative
major morbidity, defined as any major complication occur-
ring within 30 days after operation, and need for secondary
procedures, defined as any percutaneous or open surgical
procedure occurring any time from 30 days after the orig-
inal intervention.13
Analysis of data was based on the intention-to-treat
principle. Patients in whom EVAR failed and who under-
went immediate or late conversion to open surgery were
always analysed in the EVAR group. Results are reported as
median and interquartile range (IQR). Comparisons be-
tween the 2 groups were performed with the 2-sample t test
or the Mann-Whitney U test for continuous variables and
Table III. Early postoperative complications in 1119
patients
Endovascular
repair
(N  534 )
Open
repair
(N  585)
Patients with complications 49 (9.1%) 109 (18.6%)
Systemic/remote
Myocardial infarction 3 7
Congestive heart failure 3 2
Unstable angina 2 1
Arrhythmia 1 15
Pneumonia — 22
Respiratory failure 2 3
Pneumothorax — 2
Stroke 2 —
Renal failure 2 4
Renal infarction 3 —
Renal artery hemorrhage 1 —
Pancreatitis 2 4
Colon ischemia 3 2
Bowel occlusion 1 3
Bowel perforation — 2
Bleeding gastric ulcer 1 —
Acute cholecystitis — 1
Traumatic subdural hematoma 1 —
Local or vascular
Acute limb ischemia 8 14
Peripheral microembolization 4 6
Groin infection 7 2
Groin hematoma 6 —
Crossover bypass infection 1 —
Iliac artery rupture 1 —
Abdominal wound dehiscence — 9
Ureteral lesion — 2
Abdominal bleeding — 82 analysis or Fisher exact test for discrete variables. Resultsare reported with correspondent odds ratio (OR) and 95%
confidence interval (CI). Multivariable logistic regression
analysis was used to investigate associations between peri-
operative mortality and clinical variables (age, gender, car-
diac disease, chronic obstructive pulmonary disease, renal
disease, cerebrovascular disease, American Society of Anes-
thesiologists (ASA) score,14 AAA diameter, open repair,
suprarenal clamping, general anesthesia). Rates of freedom
from any death, from aneurysm-related death, and need for
secondary procedures were estimated with the Kaplan-
Meier method, with the log rank test for significance. A
2-tailed P value  .05 was considered statistically signifi-
cant. All statistical analyses were conducted with SPSS
software.
RESULTS
There were differences between the 2 treatment groups
regarding patient characteristics (Table I). In particular, in
the EVAR group there were more men (94% vs 90%),
patients were 1 year older (73 vs 72 years), and AAA
diameter was smaller (52 vs 56 mm). Patients in the EVAR
group appeared to be at higher risk for surgery, and the
incidence of coronary artery disease (46% vs 37%) and
pulmonary disease (56% vs 38%) was also higher in this
group. As a result, more patients in the EVAR group were
classified as having ASA 4 score (16% vs 6%).
Indications for open repair are shown in Table II. The
primary reason for rejection for EVAR (266 of 585 pa-
tients, 46%) was lack of adequate aortic neck (shortness or
wideness, presence of thrombus or angulation). Strictly
standard anatomy in the EVAR group was not exhibited in
207 patients (38.7%), with 1 or more factors concurrently
present: 50 patients had AAA neck length less than 15mm,
29 patients had AAA neck angle greater than 60 degrees, 38
patients had AAA neck thrombus, 68 patients had iliac
calcification, and 59 patients had aneurysms that involved
hypogastric arteries. Intraoperative data showed that oper-
ative time was 180 minutes (IQR, 150-206 minutes) in the
open repair group, compared with 120 minutes (IQR,
95-150 minutes) in the EVAR group (P  .0001). Esti-
mated blood loss was significantly lower in the EVAR
Table IV. Causes of perioperative death in patients
undergoing endovascular and open repair
Endovascular repair
(N  5)
Open repair
(N  24)
Cardiac 2 8
Bleeding 1 7
Multiple organ failure 1 2
Acute renal failure — 1
Pulmonary embolism — 1
Respiratory failure — 1
Colon ischemia — 2
Liver failure — 1
Septicemia in leukemia 1 —
Biliary peritonitis — 1group: 200 mL (IQR, 100-300 mL) versus 1400 mL
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EVAR group (4.9%) required intensive care, whereas it was
routinely used after open repair. Postoperative hospital stay
was 2 days (IQR, 2-3 days) for the EVAR group, and 6 days
(IQR, 5-7 days) for the open repair group. Incidence of
immediate conversion to open repair during primary EVAR
was 7 of 534 patients (1.3%), in 6 patients because of
impossibility to progress with the device in tortuous and
calcified iliac arteries; and in 1 patient because of proximal
infrarenal aortic neck rupture that required emergent lapa-
rotomy, followed by death from multiple organ failure.
Perioperative mortality in the EVAR group was 0.9% (5
of 534 patients), which compared favorably with open
repair mortality of 4.1% (24 of 585patients; P  .001).
More patients had perioperative major morbidity in the
open repair group compared with the EVAR group, 18.6%
(109 of 585 patients) versus 9.1% (49 of 534 patients; P
.0001). Suprarenal clamping did not affect perioperative
mortality in the open repair group: 4.2% (21 of 496 pa-
tients) with infrarenal clamping versus 3.3% (3 of 89 pa-
tients with suprarenal clamping (P  NS). Complications
Table V. Secondary procedures after EVAR
EVAR
(N  534)
Patients with secondary procedures 84 (15.7%)
Conversion to open repair 26
Splenorenal transposition 2
Iliofemoral or femorofemoral bypass 3
Axillofemoral bypass 1
Femorofemoral crossover bypass 2
Aortic or iliac endograft extension 40
Aortouniiliac endograft 11
AAA sac embolization 4
Laparoscopic inferior mesenteric artery
clipping
1
Renal artery stenting 1
Fybrinolisis plus balloon angioplasty 1
Graft limb thrombectomy 2
Major amputation 1
EVAR, Endovascular aortic aneurysm repair; AAA, abdominal aortic aneu-
rysm.
Table VI. Secondary procedures after open repair
Open repair
(N 585)
Patients with secondary procedures 17 (3%)
Repeat aortic or iliac surgery 4
Infected graft in situ replacement 2
Total graft removal and
extraanatomic bypass
1
Limb graft removal and
femorofemoral crossover bypass
1
Abdominal abscess drainage 2
Incisional hernia repair 9
Aortoiliac endografting 1are listed in Table III, and causes of death in Table IV.Follow-up ranged from 1 to 84 months (median, 33
months; IQR, 13-50 months) after EVAR, and from 1 to
90 months (median, 35 months; IQR, 15-54 months) after
open repair (P  NS).
In the EVAR group, 30-day incidence of endoleak was
9.9% (50 of 507 patients alive with endografts). At their last
control, 32 patients (6.3%) had endoleak, classified as pri-
mary persisting type 2 endoleak in 20 patients and as
secondary endoleak in 12 patients. Of the latter, 11 en-
doleaks have been classified as type 2, and only 1 was a
proximal type 1 endoleak, in a patient who died of pulmo-
nary edema before treatment. Thirty-nine patients (7.7%)
demonstrated aneurysm enlargement during follow-up,
with diameter increase greater than 5 mm with respect to
preoperative diameter. In contrast, 282 patients (55.6%)
demonstrated significant diameter decrease, greater than 5
mm.
At least 1 secondary procedure was necessary in 15.7%
of patients in the EVAR group, compared with 3% of
patients in the open repair group (P  .0001). Secondary
procedures in the EVAR and open repair groups are shown
in Tables V and VI. In the EVAR group there was no
difference in the rate of secondary procedures performed in
patients with favourable anatomy compared with patients
with unfavorable anatomy: 17% (35 of 207 patients) versus
15% (49 of 327 patients; OR, 1.1; PNS). There were no
perioperative deaths after secondary procedures in either
group. Six late AAA ruptures occurred after EVAR, 3 of
which were fatal. One late iliac pseudoaneurysm ruptured
in the open repair group, and was successfully treated. All
other causes of late deaths were not AAA-related, and are
reported in Table VII. Kaplan-Meier estimates of freedom
from aneurysm-related death at 7 years were 97.5% in the
EVAR group and 95.9% in the open repair group (log rank
test; P .008; Fig 1). Kaplan-Meier survival estimates at 7
Table VII. Causes of late death in patients undergoing
open repair and EVAR
EVAR
(N  101)
Open repair
(N  78)
n % n %
Cardiac 41 41 28 36
Malignancy 24 24 22 28
Pulmonary 7 7 4 5
Sudden death 3 3 7 9
Pulmonary embolism 1 1 3 4
Thoracic aortic rupture — 3 4
Stroke 11 11 6 8
Suicide 1 1 2 3
Renal failure 4 4 2 3
Pancreatitis — 1 1
Trauma 3 3 —
AAA rupture 3 3 —
Bleeding gastric ulcer 1 1 —
Bowel occlusion 1 1 —
Cholecystits 1 1 —
EVAR, Endovascular aortic aneurysm repair.years were 66.9% for EVAR and 67.1% for open repair (P
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for secondary intervention in the EVAR group and 7% in
the open repair group (P   .0001; Fig 3).
Effects and significance of risk factors on perioperative
mortality are shown in Table VIII. Of 11 factors analyzed
with multivariate logistic regression analysis, only open
surgery (HR, 11; 95% CI, 2.5-54.2; P  .002), ASA IV
score (HR, 7.1; 95% CI, 2.7-18.8; P  .0001) and age
(HR, 1.06; 95% CI, 1.04-1.13; P  .04) were positive
independent predictors of perioperative mortality. In par-
ticular, neither suprarenal clamping nor AAA diameter
were significantly associated with risk for perioperative
death.
DISCUSSION
The main findings of this study are that EVAR is
associated with lower early mortality and major morbidity
compared with open repair, and results in equivalent late
overall survival despite the higher risk profile of our patients
in the EVAR group. Moreover, EVAR is associated with
lower aneurysm-related mortality over the long-term, de-
spite a higher incidence of secondary procedures.
It is difficult to compare published series comparing
EVAR with open repair, because of differences in patient
characteristics, operative techniques, endograft models,
and surgical experience. Most reports are retrospective
reviews with historical open repair control subjects versus
prospectively collected EVAR cases, or populations with
different follow-up intervals, and consequent difficulty in
analysis of the results.1-6, 15-27
There is consensus in the literature that EVAR reduces
perioperative systemic complication rates when compared
with open repair; perioperative reduction in mortality after
EVAR is not so well established. All published phase II
Fig 1. Freedom from abdominal aortic aneurysm–related death
in patients undergoing open repair and endovascular aneurysm
repair (Kaplan-Meier analysis). Standard errors of displayed data
on curves did not exceed 10%.trials demonstrated similar or marginally improved mortal-ity after EVAR with a specific endograft when compared
with open repair. These studies usually included patients at
good risk, and relatively small sample sizes, which poten-
tially influenced the results. Lee et al,28 in a statewide
survey based on the 2001 National Inpatient Sample Data-
base, showed a highly statistical difference in perioperative
outcomes in 7122 patients who underwent elective treat-
ment of AAA, in favor of EVAR, with 3-fold fewer periop-
erative deaths. The reported in-hospital mortality rate after
open repair was similar to our 30-day rate (3.8% vs 4.1%);
Fig 2. Survival in patients undergoing open repair and endovas-
cular aneurysm repair (Kaplan-Meier analysis). Standard errors of
displayed data on curves did not exceed 10%.
Fig 3. Freedom from secondary procedure in patients undergo-
ing open repair and endovascular aneurysm repair (Kaplan Meier
analysis). Standard errors of displayed data on curves did not
exceed 10%.mortality after EVAR was 1.3%, close to our 0.9%. Adri-
ot sign
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results from 9 studies comparing EVAR with open repair of
AAAs. They included 1318 patients: 687 (52.1%) who
underwent EVAR and 631 (47.9%) who underwent open
repair. The pooled 30-day mortality and systemic compli-
cation rates were significantly lower for EVAR, although
differences were slight: 3% vs 4% perioperative mortality
(OR, 0.55; 95% CI, 0.33-0.92; P  .03) and 17% vs 44%
systemic complication rate (OR, 0.22; 95% CI, 0.11-0.45;
P .001) for EVAR versus open repair. On the other hand,
no significant differences were found in local complication
rates between the 2 groups.29
Our open repair mortality rate of 4.1% in a large un-
selected population compares favorably with the published
mortality rates for open AAA surgery in the endovascular
era, which range between 1.1% and 11.7% in comparative
studies.
12,16, 22-26
The wide range of open repair mortality
rates reported in the literature can be due in part to differ-
ent patient selection and inclusion criteria for high risk.
Indeed, in the present study mortality for patients with
disease classified as ASA less than 4 was 3%, compared with
19% in the subgroup at higher risk, with ASA 4 disease.
Many studies comparing EVAR versus open repair have
focused on technical success and 30-day mortality and
morbidity, whereas there is a paucity of well-controlled,
comparative studies examining long-term outcomes. On
the basis of available data, there is not enough information
to assume that EVAR reduces aneurysm-related death oc-
curring at any time after treatment.12,30
To our knowledge, this is the first report to show that
EVAR reduces late aneurysm-related death, in comparison
with open repair (2.5% vs 4.1%; P  .008). The difference
between the 2 survival curves is still striking after 7 years.
However, in the open repair group no other events were
recorded after the net drop due to perioperative mortality,
and in the EVAR group the aneurysm-related death rate
during follow-up was 0.23% per year. If we assume that the
trend of the 2 curves will be confirmed with further evalu-
ations, we can speculate that the advantage of EVAR over
open repair will be maintained for a long time. This aspect
Table VIII. Perioperative mortality: univariate analysis
Risk factors
Perioperative
mortality in patients
with risk factor
P
n %
Female gender 5/90 5.5 2
Coronary artery disease 17/464 3.7 1
Renal disease 7/118 5.9 2
Pulmonary disease 16/522 3.1 1
Cerebrovascular disease 1/136 0.7 2
ASA IV 11/123 8.9 1
Open repair 24/585 4.1
Suprarenal clamping 3/89 3.3 2
General anesthesia 26/825 3.1
ASA, American Society of Anesthesiologists; CI, confidence interval; NS, nshould be taken into account when evaluating the lifeexpectancy of the individual patient as an indication for
EVAR or open repair.
The all-cause mortality rate is similar in EVAR and
open repair, 67% in both groups at 7 years. The more
frequent inclusion of patients at high risk in the EVAR
treatment group has had an effect on overall survival, and
masks the lower rate of aneurysm-related mortality. Simi-
larly to our results, Moore et al22 reported a 5-year survival
rate of 65% for EVAR and 72% for open repair, a difference
not statistically relevant. Conversely, May et al16 found
better overall survival at 3 years after EVAR (96% for
EVAR, 85% for open repair; P  .004). The difference
between the present study and the study by May and
colleagues can be explained in part by the shorter follow-up
and the broader definition of high risk used by the authors,
ie, inclusion of patients with ASA III disease and patients
unfit for surgery because of anatomic reasons.16
In the present series we excluded from the open repair
group all patients with aneurysms that involved the renal
ostia and those with thoracoabdominal aneurysms, but we
did not exclude patients in whom suprarenal clamping of an
infrarenal aortic aneurysm was required. Although this
might be considered a potential bias, in these patients the
mortality rate was similar to that in patients with infrarenal
aortic clamping (3.3% vs 4.2%). Furthermore, suprarenal
clamping did not appear to be a significant predictor of
mortality at multivariable analysis.
Secondary procedures were required in 3% of patients
(17 of 559) undergoing open repair and in 15.7% of
patients (84 of 522) undergoing EVAR, including 26
conversions to open surgery. No perioperative mortality
was observed in either of the groups. In the 11% of patients
(126 of 1119) with overdue imaging follow-up there might
have been some with complications that would have been
treated had they been detected. However, the rate of
incomplete imaging follow-up was small and involved both
open repair and EVAR groups. Nevertheless, the repeat
intervention risk at 7 years in the EVAR group involved
almost half of the patients, and was 7 times more frequent
than in patients with a standard vascular graft. This aspect
rative mortality
tients without
isk factor
Odds
ratio 95% CI P%
29 2.3 — — NS
5 1.8 — — NS
01 2.2 2.8 1.2-6.7 .03
7 2.2 — — NS
3 2.8 — — NS
2 1.8 5.3 2.5-11.3 .0001
4 0.9 4.5 1.7-11.9 .001
30 2.5 — — NS
4 3.1 3.1 0.94-10.5 .054
ificant.eriope
in pa
r
n
4/10
2/65
2/10
3/59
8/98
8/99
5/53
6/10
3/29may limit the beneficial effect of endoluminal treatment
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especially if the patient is young, with long life expectancy.
It should be noted that two thirds of secondary proce-
dures in the EVAR group were performed endoluminally,
did not affect long-term survival, and required a short
hospital stay with fast recovery to normal life. Conversely,
95% of secondary interventions in the open repair group
required standard open procedure with the patient under
general anesthesia. In particular, it was meaningful that
about a third of the secondary procedures (6 of 17) after
open repair were to treat infection of the graft or of surgical
access, whereas no infectious complications occurred after
EVAR. The high repeat intervention rate for EVAR has
been confirmed in several studies, but most of the early
published complications with EVAR were associated with
earlier devices or early endovascular experiences.31-33 It is
hoped that new technologic development and improve-
ment will increase endograft durability, with a potential
beneficial effect on late repeat intervention rates after
EVAR. At this time, continuous clinical and instrumental
surveillance is mandatory.
The present report is limited in that it is a controlled
but not randomized study, and includes a significant num-
ber of aneurysms less than 5.5 cm in diameter. In this
regard, it should be taken into account that the study was
started before the publication of the results of randomized
clinical trials on small AAAs. Furthermore, the method of
measurement of aneurysm diameter differs from that of
previous ones, most of which use the maximum aneurysm
diameter rather than the smallest diagonal, as we did. This
could have resulted in underestimation of aneurysm diam-
eter in the present cohort.
Although limited by potential biases, the information
from the prospective design of this study, the size of the
cohort, and the duration of follow-up enable us to draw the
following conclusions. After 5 years and up to 7 years after
initial treatment, endoluminal repair offers lower aneurysm-
related mortality than standard surgical open repair. The ad-
vantage is due to lower perioperative mortality in the EVAR
group, which persisted throughout follow-up.
The consideration that almost half of the patients who
undergo EVAR will need a secondary procedure, most
likely endoluminal, makes continuous surveillance impera-
tive.
The balance between life expectancy and the expected
open surgery perioperative mortality should determine the
choice between open repair and EVAR in a patient with
suitable anatomy.
We thank Mrs Eileen Mahoney and Ms Francesca
Zannetti for editorial assistance and technical support.
REFERENCES
1. Moore WS, Brewster DC, Bernhard VM, for the EVT/Guidant Inves-
tigators. Aorto-uni-iliac endograft for complex aorto-iliac aneurysm
compared with tube/bifurcation endograft: results of the EVT/
Guidant trials. J Vasc Surg 2001;33(suppl):S11-20.
2. Zarins CK, White RA, Schwarten D, Kinney K, Diethrich EB, Hodgson
Kj, et al. AneuRx stent graft versus open surgical repair of abdominalaortic aneurysm: multicenter prospective clinical trial. J Vasc Surg
1999;29:292-308.
3. Matsumura JS, Brewster DC, Makaroun MS, Naftel DC, for the Ex-
cluder Bifurcated Endoprosthesiss Investigators. A multicenter con-
trolled clinical trial of open versus endovascular treatment of abdominal
aortic aneurysm. J Vasc Surg 2003;37:262-71.
4. Carpenter JP, Anderson WN, Brewster DC, Kwoleck C, Makaroun M,
Martin J, et al. Lifepath Investigators. Multicenter pivotal trial results of
the Lifepath system for endovascular treatment of aortic aneurysm
repair. J Vasc Surg 2004;39:34-42.
5. Greenberg R. The Zenith endograft for abdominal aotic aneurysms:
clinical update. Semin Vasc Surg 2003;16:151-7.
6. Criado FJ, Wilson EP, Fairman RM, Abul-Khoudoud O, Wellons E.
Update on the Talent LPS AAA stent graft: results with “Enhanced
Talent.” Semin Vasc Surg 2003;16:158-65.
7. Cao P, Verzini F, Zannetti S, De Rango P, Parlani G, Lupattelli L, et al.
Device migration after endoluminal abdominal aortic aneurysm repair:
analysis of 113 cases with a minimum follow-up period of 2 years. J Vasc
Surg 2002;35:229-35.
8. Harris PL, Vallbhaneni SR, Desgranges P, Becquemin JP, van Mar-
rewijk C, Laheij RJF, for the EUROSTAR Collaborators. Incidence and
risk factor of late rupture, conversion, and death after endovascular
repair of infrarenal aortic aneurysms: The EUROSTAR experience. J
Vasc Surg 2000;32: 739-49.
9. Zarins CK, White RA, Fogarty TJ. Aneurysm rupture after endovascular
repair using the AneuRx stent graft. J Vasc Surg 2000;31:960-70.
10. Dattilo JB, Brewster DC, Fan C-M, Geller SC, Cambria RP, LaMura-
glia GM, et al. Clinical failures on endovascular abdominal aortic
aneurysm repair: incidence, causes, and management. J Vasc Surg
2002;35:1137-44.
11. Chaikof EL, Fillinger MF, Matsumura JS, Rutherford RB, White GH,
Blankensteijn JD, et al. Indentifyng and grading factors that modify the
outcome of endovascular aortic aneurysm repair. J Vasc Surg 2002;35:
1061-6.
12. Arko FR, Lee A, Hill BB, Olcott C IV, Dalman RL, Harris EJ, et al.
Aneurysm-related death: primary endpoint analysis for comparison of
open and endovascular repair. J Vasc Surg 2002;36:297-304.
13. Ad Hoc Committee for Standardized Reporting Practices in Vascular
Surgery of the Society for Vascular Surgery/American Association for
Vascular Surgery, Chaikof EL, Bernahrd VM, Blankensteijn JD, Harris
PL, White GH, et al. Revised reporting standards for endovascular
aortic aneurysm repair. J Vasc Surg 2002;35:1048-59.
14. Dentz ME. Grichnik KP, Sibert KS, Reves JG. Anesthesia and postop-
erative analgesia. In: Sabiston DC Jr, Lyerly HK, editors. Textbook of
surgery. 15th ed. Philadelphia (PA): Saunders; 1997. p 186-206.
15. May J, White GH, Yu W, Ly CN, Waugh R, Stephen MS, et al.
Concurrent comparison of endoluminal versus open repair in treatment
of adominal aneurysm: analysis of 303 patients by life-table method. J
Vasc Surg 1998;27:213-21.
16. May J, White GH, Waugh R, Ly CN, Stephen MS, Jones MA, et al.
Improved survival after endoluminal repair with second generation
prostheses compared with open repair in the treatment of abdominal
aortic aneurysms: a 5-year concurrent comparison using life table
method. J Vasc Surg 2001;33(suppl):S21-6
17. White GH, May J, McGahan T, Yu W, Waugh RC, Stephen MS, et al.
Historic control comparison of outcome for matched groups of patients
undergoing endoluminal versus open repair of abdominal aortic aneu-
rysms. J Vasc Surg 1996;23:201-12.
18. Brewster DC, Geller SC, Kaufman JA, Cambria RP, Gertler JP, GM
LaMuraglia , et al. Initial experience with endovascular aneurysm repair:
comparison of early results with outcome of conventional open repair. J
Vasc Surg 1998;27:992-1005.
19. Ligush J Jr, Pearce JD, Edwards MS, Eskridge MR, Cherr GS, Plonk
GW, et al. Analysis of medical risk factors and outcomes in patients
undergoing open versus endovascular abdominal aortic aneurysm re-
pair. J Vasc Surg 2002;36:492-9.
20. De Virgilio C, Bui H, Donayre C, Ephraim L, Lewis RL, Elbassir M,
Stabile BE, et al. Endovascular vs open abdominal aortic aneurysm
repair: A comparison of cardiac morbidity and mortality. Arch Surg
1999;134:947-51.
JOURNAL OF VASCULAR SURGERY
November 2004848 Cao et al21. Carpenter JP, Baum RA, Barker CF, Golden MA, Velazquez OC,
Mitchell ME, et al. Durability of benefits of endovascular versus con-
ventional abdominal aortic aneurysm repair. J Vasc Surg 2002;35:
222-8.
22. Moore WS, Kashyap VS, Vescera CL, Quinones-Baldrich WJ. Abdom-
inal aortic aneurysm: 6 year comparison of endovascular versus transab-
dominal repair. Ann Vasc Surg 1999;230:298-306.
23. Becquemin J, Bourriez A, D’Audiffret A, Zubilewicz T, Kobeiter H,
Allaire E, et al. Mid term results of endovascular versus open repair for
abdominal aortic aneurysm repair in patients anatomically suitable for
endovascular repair. Eur J Vasc Endovasc Surg 2000; 9:656-61.
24. Dias NV, Ivancev K, Malina M, Resch T, Lindblad, Sonesson B. Does
the wide application of endovascular AAA repair affect the results of
open surgery? Eur J Vasc Endovasc Surg 2003;26:188-94.
25. Elkouri S, Gloviczki P, McKusick MA, Panneton JM, Andrews J, Bower
TC, et al. Perioperative complications and early outcome after endovas-
cular and open surgical repair of abdominal aortic aneurysms. J Vasc
Surg 2004;39:497-505.
26. Teufelsbauer H, Prusa AM, Wolff K, Polterauer P, Nanobashvili J,
Prager M, et al. Endovascular stent grafting versus open surgical oper-
ation in patients with infrarenal aortic aneurysms: a propensity score-
adjusted analysis. Circulation 2002;106:782-7.
27. Cohnert TU, Oelert F, Wahlers T, Gohrbandt B, Chaven A, Farber A,
et al. Matched pair analysis of conventional versus endoluminal AAA
ence?treatment outcomes during the initial phases of an endografting
program. J Endovasc Ther 2000;7:94-100.
28. Lee WA, Carter JW, Upchurch G, Seeger JM, Huber TS. Perioperative
outcomes after open and endovascular repair of an intact abdominal
aortic aneurysm in the United States during 2001. J Vasc Surg 2004;
39:491-6.
29. Adriaensen MEAPM, Bosch JL, Halpern EF, Hunink MGM, Gazzelle
GS. Elective endovascular versus open surgical repair of abdominal
aortic aneurysms: systematic review of short term results. Radiology
2002;224:739-47.
30. Rutherford RB, Krupski WC. Current status of open versus endovascu-
lar stent graft repair of abdominal aortic aneurysm. J Vasc Surg 2004:
39:1129-39.
31. Beebe HG, Cronenwett JL, Katzen BT, Brewster DC, Green RM.
Vanguard Endograft Trial Investigators. Results of an aortic endograft
trial: impact of device failure beyond 12 months. J Vasc Surg 2001;
33(suppl):S55-63.
32. Alric P, Hinchliffe RJ, Wenham PW, Whitaker SC, Chuter TA,
Hopkinson BR. Lessons learned from the long-term follow-up of a
first-generation aortic stent graft. J Vasc Surg 2003;37:367-73.
33. Jacobs TS, Won J, Gravereaux EC, Faries PL, Morrissey N, Teodorescu
VJ, et al. Mechanical failure of prosthetic human implants: a 10-year
experience with aortic stent graft devices. J Vasc Surg 2003;37:16-26.Submitted Jun 14, 2004; accepted Aug 29, 2004.DISCUSSION
Dr Frank Arko (Stanford, Calif). Dr. Cao and coworkers
treated 1119 patients with abdominal aortic aneurysms over 7
years with excellent results. Of these, 48% underwent endovascular
repair, and 52% of the patients were treated with open repair. More
important, the vast majority of these patients, 90%, were treated
with currently FDA-approved devices. Their perioperative mortal-
ity for endovascular repair was exceptional at less than 1%, as well as
for open repair at 4.1%. Furthermore, their perioperative major
morbidity was significantly reduced after endovascular repair com-
pared with open repair, 9.1% versus 18.6%. More important, the
authors showed a significant improvement in freedom from aneu-
rysm-related death after endovascular repair compared with open
surgery. Unfortunately, at 7 years nearly 49% of the patients
required a secondary procedure after endovascular repair. I have
the following questions for the authors.
Why did the authors include 84 patients who required supra-
renal cross-clamps or renal artery reconstructions, which techni-
cally are more challenging and often associated with higher mor-
tality? If these patients are excluded, is there a difference in their
perioperative mortality or freedom from aneurysm-related death?
Next, the authors state that the exclusion criteria for endovas-
cular repair were aortic neck length less than 15 mm or greater than
30 mm, proximal neck angle greater than 60 degrees, neck throm-
bus, and iliac occlusive disease. However, these anatomic criteria
were less stringent in their high-risk patients. With the high rate,
49%, of secondary procedures in patients undergoing EVAR, do
the authors know how many occurred in those treated with these
less stringent anatomic criteria?
Next, nearly half of the secondary procedures after EVAR were
proximal or distal extended cuffs. There were a total of 40. Since
1999 our practice at Stanford has been to routinely endograft from
the renal arteries to the hypogastric arteries bilaterally, which has
significantly reduced our number of secondary procedures. Have
the authors noticed a similar learning curve in their own experi-Next, can the authors explain the cause of surgical conversions
in 26 patients after endovascular repair and the 6 ruptures resulting
in 3 deaths?
And finally, my last question is regarding aneurysm size. The
mean aneurysm size for endovascular aneurysm repair is only 52
mm, compared with 56 mm. How many of the 534 patients
undergoing EVAR had aneurysms less than 5.5 cm? And do the
authors have any data on freedom from aneurysm-related death in
patients with small aneurysms undergoing surveillance compared
with EVAR?
Dr Fabio Verzini. Regarding your question about suprarenal
clamping, we like to have a picture as close as possible to the real
world. We excluded all the aneurysms that involved the renal ostia,
but we did not exclude the patients with suprarenal clamping. This
led to a mortality rate that was very similar to that of the patients
with infrarenal aortic clamping. Our mortality for suprarenal
clamping was 3.3%, actually the same as for the other patients.
About the high-risk patients and anatomic criteria, we already
addressed this topic by investigating the rate of migration and rate
of aortic neck dilatation after endografting, and found that only
aneurysm diameter and neck diameter are significantly associated
with need for reoperations.
About our learning curve, I completely agree with you. Our
tendency today is to use suprarenal fixation more extensively and to
do extensive coverage of the iliac arteries. This will probably lead to
a lower reintervention rate in the long term.
About the smaller diameter of the endografting group, it may
well be that there is some underestimation of the diameter in our
population, because we measure the smallest diameter on the axial
CT as the diameter of the aneurysm. In our opinion, a 4-mm
difference between the 2 groups might not be clinically relevant. In
the group with smaller aneurysms treated with endografting we
had a better aneurysm-related death rate starting from the early
results, with a mortality rate of 0.2% at 30 days.
